Reinforcing customer competitiveness
The Services segment comprises logistics services for the Swiss healthcare market from Alloga (pre-wholesale), Galexis, Unione Farmaceutica Distribuzione and Pharmapool (wholesale), as well as Medifilm, which is active in drug blister packaging. These services are complemented by services from HCI Solutions, which provides master data for the Swiss healthcare market and develops management solutions for pharmacies as well as tools for secure management, communication and distribution of sensitive health data.
Net sales and operating result
The Services segment generated net sales of CHF 1,233.6 million in the first six months of 2017. The sales growth of 7.4% was due in particular to the successful integration of Pharmapool. This was achieved in an overall market whose growth (+3.9%, IMS Health first half of 2017) was driven especially by the sales performance of hospitals (+7.6%, IMS Health first half of 2017) as well as high-priced special medications that are not supplied via wholesale but directly to specialist doctors (doctors: +5.4%, IMS Health first half of 2017).
The sales growth of 7.4% was due in particular to the successful integration of Pharmapool.
The operating result (EBIT) improved by 41.9% to CHF 28.7 million. Included in EBIT are one-off positive effects from the sale of the rights of the TriaMed® medical practice software to Swisscom and the sale of a non-operational building in Schönbühl (canton of Bern), which totalled CHF 7.0 million. Excluding these one-off effects, ROS remained unchanged from the previous year at 1.8%.
Investments in the first half of 2017 amounted to CHF 11.1 million, used notably to finance the new ERP software that will gradually be rolled out at Alloga and Galexis over the next few years.
Tel. +41 58 852 81 11
Fax +41 58 852 81 12